Literature DB >> 18499406

Schizophrenia: from developmental deviance to dopamine dysregulation.

Robin M Murray1, Julia Lappin, Marta Di Forti.   

Abstract

Two major theories of schizophrenia are respectively, the neurodevelopmental hypothesis and the dopamine hypothesis. Each of these has recently been revised. Firstly, the classical neurodevelopmental hypothesis has been modified to include the pathogenic effects of psychostimulants and cannabis abuse, and also of chronic social adversity; it is perhaps now more appropriately termed, the developmental hypothesis. Secondly, recent amendments to the dopamine hypothesis suggest that excess striatal dopamine is responsible for increased salience being given to insignificant events and thoughts, and that this underpins the development of psychotic symptoms. Traditionally, it has been thought that this striatal dopamine dysregulation might be secondary to frontal dysfunction. However, recent animal research shows that over-expression of striatal D(2) receptors results in frontal dysfunction manifesting as cognitive difficulties and animal equivalents of so-called negative symptoms. This raises the question whether early intervention may prevent the development of these latter problems. Finally, the two theories are beginning to be integrated through the growing evidence that all the developmental risk factors which increase risk of schizophrenia appear to act by facilitating dopamine dysregulation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18499406     DOI: 10.1016/j.euroneuro.2008.04.002

Source DB:  PubMed          Journal:  Eur Neuropsychopharmacol        ISSN: 0924-977X            Impact factor:   4.600


  39 in total

1.  Prefrontal and striatal volumes in monozygotic twins concordant and discordant for schizophrenia.

Authors:  Ulrich Ettinger; Anne Schmechtig; Timothea Toulopoulou; Charmaine Borg; Claire Orrells; Sheena Owens; Kazunori Matsumoto; Neeltje E van Haren; Mei-Hua Hall; Veena Kumari; Philip K McGuire; Robin M Murray; Marco Picchioni
Journal:  Schizophr Bull       Date:  2010-06-10       Impact factor: 9.306

2.  Migration, ethnicity, and psychosis: toward a sociodevelopmental model.

Authors:  Craig Morgan; Monica Charalambides; Gerard Hutchinson; Robin M Murray
Journal:  Schizophr Bull       Date:  2010-05-30       Impact factor: 9.306

3.  High precision liquid chromatography analysis of dopaminergic and serotoninergic responses to acute alcohol exposure in zebrafish.

Authors:  Diptendu Chatterjee; Robert Gerlai
Journal:  Behav Brain Res       Date:  2009-06-08       Impact factor: 3.332

Review 4.  Progress in defining optimal treatment outcome in schizophrenia.

Authors:  Gary Remington; George Foussias; Ofer Agid
Journal:  CNS Drugs       Date:  2010-01       Impact factor: 5.749

5.  Neonatal quinpirole treatment enhances locomotor activation and dopamine release in the nucleus accumbens core in response to amphetamine treatment in adulthood.

Authors:  Zackary A Cope; Kimberly N Huggins; A Brianna Sheppard; Daniel M Noel; David S Roane; Russell W Brown
Journal:  Synapse       Date:  2010-04       Impact factor: 2.562

6.  Mutant mouse models: genotype-phenotype relationships to negative symptoms in schizophrenia.

Authors:  Colm M P O'Tuathaigh; Brian P Kirby; Paula M Moran; John L Waddington
Journal:  Schizophr Bull       Date:  2009-11-24       Impact factor: 9.306

7.  Heritability of acoustic startle magnitude, prepulse inhibition, and startle latency in schizophrenia and control families.

Authors:  Wendy Hasenkamp; Michael P Epstein; Amanda Green; Lisette Wilcox; William Boshoven; Barbara Lewison; Erica Duncan
Journal:  Psychiatry Res       Date:  2010-05-16       Impact factor: 3.222

8.  Attitudes towards cannabis use and genetic testing for schizophrenia.

Authors:  Jason Schiffman; Ryan E Lawrence; Caroline Demro; Paul S Appelbaum; Lisa B Dixon
Journal:  Early Interv Psychiatry       Date:  2014-06-23       Impact factor: 2.732

9.  Two four-marker haplotypes on 7q36.1 region indicate that the potassium channel gene HERG1 (KCNH2, Kv11.1) is related to schizophrenia: a case control study.

Authors:  Fatmahan Atalar; Tufan Tevfik Acuner; Naci Cine; Fatih Oncu; Dogan Yesilbursa; Ugur Ozbek; Solmaz Turkcan
Journal:  Behav Brain Funct       Date:  2010-05-28       Impact factor: 3.759

Review 10.  Prenatal exposure to infection: a primary mechanism for abnormal dopaminergic development in schizophrenia.

Authors:  Urs Meyer; Joram Feldon
Journal:  Psychopharmacology (Berl)       Date:  2009-03-11       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.